▶ 調査レポート

脊椎インプラントの世界市場2022-2031:産業分析、規模、シェア、成長、動向、予測

• 英文タイトル:Intervertebral Implants Market (Type: Cervical, Lumbar, and Others; and Material: Titanium, Polyetheretherketone, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Transparency Market Researchが調査・発行した産業分析レポートです。脊椎インプラントの世界市場2022-2031:産業分析、規模、シェア、成長、動向、予測 / Intervertebral Implants Market (Type: Cervical, Lumbar, and Others; and Material: Titanium, Polyetheretherketone, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031 / MRC2301F0066資料のイメージです。• レポートコード:MRC2301F0066
• 出版社/出版日:Transparency Market Research / 2022年11月24日
• レポート形態:英文、PDF、185ページ
• 納品方法:Eメール
• 産業分類:医療機器
• 販売価格(消費税別)
  Single User¥869,250 (USD5,795)▷ お問い合わせ
  Multi User¥1,319,250 (USD8,795)▷ お問い合わせ
  Corporate License¥1,769,250 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
トランスペアレンシー・マーケット・リサーチ社の当調査資料では、世界の脊椎インプラント市場について総合的に調査・分析を行い、序論、仮定・調査手法、市場概要、主要インサイト、種類別(頚椎インプラント、腰椎インプラント、その他)分析、材質別(チタン、ポリエーテルエーテルケトン、その他)分析、エンドユーザー別(病院、外来手術センター、その他)分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東/アフリカ)分析、競争状況、企業情報などの項目を掲載しています。なお、当市場の主要企業には、Alphatec Spine, Inc.、B. Braun Melsungen AG、Companion Spine LLC、DePuy Synthes (Johnson & Johnson)、Globus Medical, Inc.、LASAK s.r.o.、NuVasive, Inc.、Spineology Inc.、Stryker Corporation、Xtant Medicalなどが含まれています。
・序論
・仮定・調査手法
・市場概要
・主要インサイト

・世界の脊椎インプラント市場規模:種類別
- 頚椎インプラントの市場規模
- 腰椎インプラントの市場規模
- その他種類の市場規模

・世界の脊椎インプラント市場規模:材質別
- チタンの市場規模
- ポリエーテルエーテルケトンの市場規模
- その他材質の市場規模

・世界の脊椎インプラント市場規模:エンドユーザー別
- 病院における市場規模
- 外来手術センターにおける市場規模
- その他エンドユーザーにおける市場規模

・世界の脊椎インプラント市場規模:地域別
- 北米の脊椎インプラント市場規模
- ヨーロッパの脊椎インプラント市場規模
- アジア太平洋の脊椎インプラント市場規模
- 中東/アフリカの脊椎インプラント市場規模
- 中南米の脊椎インプラント市場規模

・競争状況
・企業情報

Intervertebral Implants Market – Scope of Report
TMR’s report on the global intervertebral implants market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global intervertebral implants market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global intervertebral implants market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the intervertebral implants market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global intervertebral implants market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global intervertebral implants market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global intervertebral implants market.

The report delves into the competitive landscape of the global intervertebral implants market. Key players operating in the global intervertebral implants market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global intervertebral implants market profiled in this report.

RESEARCH METHODOLOGY

The research methodology will be a combination of exhaustive primary and secondary research to analyze the market intervertebral implants.

Secondary Research

Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.

Secondary research sources that we typically refer, but are not limited to:

Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market

Specific Secondary Sources:

Industry Sources:
WorldWideScience.org
Elsevier, Inc.
National Institutes of Health (NIH)
PubMed
NCBI
Department of Health Care Service
Trade Data Sources
Trade Map
UN Comtrade
Trade Atlas
Company Information
OneSource Business Browser
Hoover’s
Factiva
Bloomberg
Mergers & Acquisitions
Thomson Mergers & Acquisitions
MergerStat
Profound

Primary Research

During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.

We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:

Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies

Participants who typically take part in such a process include, but are not limited to:

Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals

List of primary participants, but not limited to:

Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.

Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.

Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:

Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities

Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.

レポート目次

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Intervertebral Implants Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Intervertebral Implants Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Technological Advancements
5.2. Disease Prevalence & Incidence Rate globally
5.3. Pricing Analysis
5.4. Key Industry Events (Mergers, Acquisitions, Partnerships, Collaborations, etc.)
5.5. COVID-19 Pandemic Impact on Industry
6. Global Intervertebral Implants Market Analysis and Forecast, By Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast By Type, 2017–2031
6.3.1. Cervical
6.3.2. Lumbar
6.3.3. Others
6.4. Market Attractiveness By Type
7. Global Intervertebral Implants Market Analysis and Forecast, By Material
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast By Material, 2017–2031
7.3.1. Titanium
7.3.2. Polyetheretherketone (PEEK)
7.3.3. Others
7.4. Market Attractiveness By Material
8. Global Intervertebral Implants Market Analysis and Forecast, By End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast By End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Ambulatory Surgical Centers
8.3.3. Clinics and Orthopedic Centers
8.4. Market Attractiveness By End-user
9. Global Intervertebral Implants Market Analysis and Forecast, By Region
9.1. Key Findings
9.2. Market Value Forecast By Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness By Country/Region
10. North America Intervertebral Implants Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast By Type, 2017–2031
10.2.1. Cervical
10.2.2. Lumbar
10.2.3. Others
10.3. Market Value Forecast By Material, 2017–2031
10.3.1. Titanium
10.3.2. Polyetheretherketone (PEEK)
10.3.3. Others
10.4. Market Value Forecast By End-user, 2017–2031
10.4.1. Hospitals
10.4.2. Ambulatory Surgical Centers
10.4.3. Clinics and Orthopedic Centers
10.5. Market Value Forecast By Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Type
10.6.2. By Material
10.6.3. By End-user
10.6.4. By Country
11. Europe Intervertebral Implants Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Type, 2017–2031
11.2.1. Cervical
11.2.2. Lumbar
11.2.3. Others
11.3. Market Value Forecast By Material, 2017–2031
11.3.1. Titanium
11.3.2. Polyetheretherketone (PEEK)
11.3.3. Others
11.4. Market Value Forecast By End-user, 2017–2031
11.4.1. Hospitals
11.4.2. Ambulatory Surgical Centers
11.4.3. Clinics and Orthopedic Centers
11.5. Market Value Forecast By Country/Sub-Region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Type
11.6.2. By Material
11.6.3. By End-user
11.6.4. By Country/Sub-Region
12. Asia Pacific Intervertebral Implants Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Type, 2017–2031
12.2.1. Cervical
12.2.2. Lumbar
12.2.3. Others
12.3. Market Value Forecast By Material, 2017–2031
12.3.1. Titanium
12.3.2. Polyetheretherketone (PEEK)
12.3.3. Others
12.4. Market Value Forecast By End-user, 2017–2031
12.4.1. Hospitals
12.4.2. Ambulatory Surgical Centers
12.4.3. Clinics and Orthopedic Centers
12.5. Market Value Forecast By Country/Sub-Region, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Type
12.6.2. By Material
12.6.3. By End-user
12.6.4. By Country/Sub-Region
13. Latin America Intervertebral Implants Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Type, 2017–2031
13.2.1. Cervical
13.2.2. Lumbar
13.2.3. Others
13.3. Market Value Forecast By Material, 2017–2031
13.3.1. Titanium
13.3.2. Polyetheretherketone (PEEK)
13.3.3. Others
13.4. Market Value Forecast By End-user, 2017–2031
13.4.1. Hospitals
13.4.2. Ambulatory Surgical Centers
13.4.3. Clinics and Orthopedic Centers
13.5. Market Value Forecast By Country/Sub-Region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Type
13.6.2. By Material
13.6.3. By End-user
13.6.4. By Country/Sub-Region
14. Middle East & Africa Intervertebral Implants Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast By Type, 2017–2031
14.2.1. Cervical
14.2.2. Lumbar
14.2.3. Others
14.3. Market Value Forecast By Material, 2017–2031
14.3.1. Titanium
14.3.2. Polyetheretherketone (PEEK)
14.3.3. Others
14.4. Market Value Forecast By End-user, 2017–2031
14.4.1. Hospitals
14.4.2. Ambulatory Surgical Centers
14.4.3. Clinics and Orthopedic Centers
14.5. Market Value Forecast By Country/Sub-Region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Type
14.6.2. By Material
14.6.3. By End-user
14.6.4. By Country/Sub-Region
15. Competition Landscape
15.1. Market Player – Competition Matrix (By Tier and Size of Companies)
15.2. Company Profiles
15.2.1. Alphatec Spine, Inc.
15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.1.2. Product Portfolio
15.2.1.3. Financial Overview
15.2.1.4. SWOT Analysis
15.2.1.5. Strategic Overview
15.2.2. B. Braun Melsungen AG
15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.2.2. Product Portfolio
15.2.2.3. Financial Overview
15.2.2.4. SWOT Analysis
15.2.2.5. Strategic Overview
15.2.3. Companion Spine LLC
15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.3.2. Product Portfolio
15.2.3.3. Financial Overview
15.2.3.4. SWOT Analysis
15.2.3.5. Strategic Overview
15.2.4. DePuy Synthes (Johnson & Johnson)
15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.4.2. Product Portfolio
15.2.4.3. Financial Overview
15.2.4.4. SWOT Analysis
15.2.4.5. Strategic Overview
15.2.5. Globus Medical, Inc.
15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.5.2. Product Portfolio
15.2.5.3. Financial Overview
15.2.5.4. SWOT Analysis
15.2.5.5. Strategic Overview
15.2.6. LASAK s.r.o.
15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.6.2. Product Portfolio
15.2.6.3. Financial Overview
15.2.6.4. SWOT Analysis
15.2.6.5. Strategic Overview
15.2.7. NuVasive, Inc.
15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.7.2. Product Portfolio
15.2.7.3. Financial Overview
15.2.7.4. SWOT Analysis
15.2.7.5. Strategic Overview
15.2.8. Spineology Inc.
15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.8.2. Product Portfolio
15.2.8.3. Financial Overview
15.2.8.4. SWOT Analysis
15.2.8.5. Strategic Overview
15.2.9. Stryker Corporation
15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.9.2. Product Portfolio
15.2.9.3. Financial Overview
15.2.9.4. SWOT Analysis
15.2.9.5. Strategic Overview
15.2.10. Xtant Medical
15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.10.2. Product Portfolio
15.2.10.3. Financial Overview
15.2.10.4. SWOT Analysis
15.2.10.5. Strategic Overview